PURPOSE: In patients with chronic kidney disease, survival has been shown to be better with increasing body mass, an observation which was termed the "obesity paradox". To investigate if such an effect would also be present in patients with acute kidney injury (AKI), we analysed the impact of body mass on the prognosis of intensive care patients with severe AKI requiring renal replacement therapy. METHODS: A total of 5,232 patients with AKI requiring renal replacement therapy from 53 Austrian ICUs were analysed. RESULTS: Patients were divided into one of five BMI groups: underweight, normal, overweight, obese and morbid obese. The incidence of AKI increased with increasing body mass from underweight, normal (5.4%) to morbid obese (11.8%). Moreover, adjusted odds ratios to develop AKI were significantly increased for all groups (reference group: normal). Risk-adjusted hospital mortality rates followed a U-shaped pattern, with the lowest mortality in obese patients (BMI of > or = 30 < 35). Multivariate analysis (with adjustment for severity of illness, sex, reason for admission and comorbidities) confirmed these results: obese patients presented with a significantly reduced probability to die in the hospital [odds ratio 0.81 (0.66-0.98)]. CONCLUSIONS: Obesity is an independent risk factor for developing AKI. Our results provide further evidence that body mass impacts on survival of patients with AKI requiring renal replacement therapy. Obese patients seem to have a survival benefit compared to underweight or normal weight patients.
PURPOSE: In patients with chronic kidney disease, survival has been shown to be better with increasing body mass, an observation which was termed the "obesity paradox". To investigate if such an effect would also be present in patients with acute kidney injury (AKI), we analysed the impact of body mass on the prognosis of intensive care patients with severe AKI requiring renal replacement therapy. METHODS: A total of 5,232 patients with AKI requiring renal replacement therapy from 53 Austrian ICUs were analysed. RESULTS:Patients were divided into one of five BMI groups: underweight, normal, overweight, obese and morbid obese. The incidence of AKI increased with increasing body mass from underweight, normal (5.4%) to morbid obese (11.8%). Moreover, adjusted odds ratios to develop AKI were significantly increased for all groups (reference group: normal). Risk-adjusted hospital mortality rates followed a U-shaped pattern, with the lowest mortality in obesepatients (BMI of > or = 30 < 35). Multivariate analysis (with adjustment for severity of illness, sex, reason for admission and comorbidities) confirmed these results: obesepatients presented with a significantly reduced probability to die in the hospital [odds ratio 0.81 (0.66-0.98)]. CONCLUSIONS:Obesity is an independent risk factor for developing AKI. Our results provide further evidence that body mass impacts on survival of patients with AKI requiring renal replacement therapy. Obesepatients seem to have a survival benefit compared to underweight or normal weight patients.
Authors: S R Bornstein; J Licinio; R Tauchnitz; L Engelmann; A B Negrão; P Gold; G P Chrousos Journal: J Clin Endocrinol Metab Date: 1998-01 Impact factor: 5.958
Authors: P G Metnitz; H Vesely; A Valentin; C Popow; M Hiesmayr; K Lenz; C G Krenn; H Steltzer Journal: Crit Care Med Date: 1999-08 Impact factor: 7.598
Authors: Amy E Morris; Renee D Stapleton; Gordon D Rubenfeld; Leonard D Hudson; Ellen Caldwell; Kenneth P Steinberg Journal: Chest Date: 2007-02 Impact factor: 9.410
Authors: Nathan W Levin; Garry J Handelman; Josef Coresh; Friedrich K Port; George A Kaysen Journal: Semin Dial Date: 2007 Nov-Dec Impact factor: 3.455
Authors: Kamyar Kalantar-Zadeh; Kevin C Abbott; Abdulla K Salahudeen; Ryan D Kilpatrick; Tamara B Horwich Journal: Am J Clin Nutr Date: 2005-03 Impact factor: 7.045
Authors: Michael G S Shashaty; Nuala J Meyer; A Russell Localio; Robert Gallop; Scarlett L Bellamy; Daniel N Holena; Paul N Lanken; Sandra Kaplan; Dilek Yarar; Steven M Kawut; Harold I Feldman; Jason D Christie Journal: J Crit Care Date: 2012-05-15 Impact factor: 3.425
Authors: Frederic T Billings; Mias Pretorius; Jonathan S Schildcrout; Nathaniel D Mercaldo; John G Byrne; T Alp Ikizler; Nancy J Brown Journal: J Am Soc Nephrol Date: 2012-05-24 Impact factor: 10.121
Authors: Michael G S Shashaty; Esra Kalkan; Scarlett L Bellamy; John P Reilly; Daniel N Holena; Kathleen Cummins; Paul N Lanken; Harold I Feldman; Muredach P Reilly; Jayaram K Udupa; Jason D Christie Journal: Crit Care Med Date: 2014-07 Impact factor: 7.598
Authors: John Danziger; Ken P Chen; Joon Lee; Mengling Feng; Roger G Mark; Leo Anthony Celi; Kenneth J Mukamal Journal: Crit Care Med Date: 2016-02 Impact factor: 7.598